$110,000 of LEGEND BIOTECH CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Advance Legend Biotech's interests with respect to educating member of Congress on the importance of the role of biotechnology in healthcare"
You can find more data on corporate lobbying on Quiver Quantitative.
LEGN Hedge Fund Activity
We have seen 105 institutional investors add shares of LEGN stock to their portfolio, and 113 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 12,466,098 shares (+94.4%) to their portfolio in Q2 2025, for an estimated $442,421,818
- PRICE T ROWE ASSOCIATES INC /MD/ removed 5,929,559 shares (-88.1%) from their portfolio in Q2 2025, for an estimated $210,440,048
- DEERFIELD MANAGEMENT COMPANY, L.P. added 2,962,338 shares (+inf%) to their portfolio in Q2 2025, for an estimated $105,133,375
- INVESCO LTD. removed 2,919,873 shares (-99.4%) from their portfolio in Q2 2025, for an estimated $103,626,292
- WELLINGTON MANAGEMENT GROUP LLP removed 1,857,268 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $65,914,441
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,824,735 shares (-80.4%) from their portfolio in Q2 2025, for an estimated $64,759,845
- ARTISAN PARTNERS LIMITED PARTNERSHIP added 990,500 shares (+87.5%) to their portfolio in Q2 2025, for an estimated $35,152,845
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LEGN Analyst Ratings
Wall Street analysts have issued reports on $LEGN in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 10/17/2025
- Cantor Fitzgerald issued a "Overweight" rating on 08/27/2025
- Morgan Stanley issued a "Overweight" rating on 08/12/2025
- RBC Capital issued a "Outperform" rating on 08/12/2025
- UBS issued a "Buy" rating on 07/02/2025
- Truist Securities issued a "Buy" rating on 05/14/2025
To track analyst ratings and price targets for LEGN, check out Quiver Quantitative's $LEGN forecast page.
LEGN Price Targets
Multiple analysts have issued price targets for $LEGN recently. We have seen 10 analysts offer price targets for $LEGN in the last 6 months, with a median target of $73.0.
Here are some recent targets:
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $60.0 on 10/17/2025
- Jessica Fye from JP Morgan set a target price of $76.0 on 10/09/2025
- Eric Schmidt from Cantor Fitzgerald set a target price of $66.0 on 08/27/2025
- Matthew Harrison from Morgan Stanley set a target price of $83.0 on 08/12/2025
- Leonid Timashev from RBC Capital set a target price of $77.0 on 08/12/2025
- Ashwani Verma from UBS set a target price of $54.0 on 07/02/2025
- Asthika Goonewardene from Truist Securities set a target price of $71.0 on 05/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
